首页
数据库
关于我们
联系我们
您当前的位置： 首页 > 数据库
所属年份
2008 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
到
2008 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
检索 清除
手术分类
  • 全部（2447）
  • 腹部手术（342）
  • 胸科手术（70）
  • 血管手术（5）
  • 心脏手术（97）
  • 神经外科（4）
  • 头颈部（35）
  • 骨科（78）
  • 泌尿外科（0）
  • 妇产手术（77）
  • 日间手术（26）
  • 手术室外（28）
  • 创伤和烧伤（0）
  • 非心脏手术（472）
  • 老年（0）
  • 小儿新生儿（189）
  • 特殊患者（42）
  • 未说明手术类型（982）
阶段管理
  • 术前宣教（21）
  • 术前评估（33）
  • 术前用药（15）
  • 术前禁食水（12）
  • 麻醉选择（21）
  • 麻醉用药（10）
  • 术中监测（23）
  • 液体管理（14）
  • 血液保护（3）
  • 体温管理（8）
  • 术后疼痛（62）
  • POD（8）
  • PONV（10）
  • 术后康复（50）
  • 特殊情况（43）
  • 术前肠道准备（9）
排序：
发表时间 阅读量
Array ( [id] => 2219 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2219.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => For patients with carotid artery disease undergoing non-cardiac surgery(NCS),the same indications for carotid revascularization should be considered as for other patients with carotid stenosis.(Evidence: Level C，Recommendation: Class IIa) [laiyuan] => NCS患者合并颈动脉疾病时行颈动脉血运重建的适应证与其它颈动脉疾病一致。（证据级别：C；推荐强度：IIa） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
NCS患者合并颈动脉疾病时行颈动脉血运重建的适应证与其它颈动脉疾病一致。（证据级别：C；推荐强度：IIa）

For patients with carotid artery disease undergoing non-cardiac surgery(NCS),the same indications for carotid revascularization should be considered as for other patients with carotid stenosis.(Evidence: Level C，Recommendation: Class IIa)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2220 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2220.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Preoperative carotid artery imaging is not recommended routinely in patients undergoing non-cardiac surgery(NCS).(Evidence: Level C，Recommendation: Class III) [laiyuan] => 不建议NCS患者术前行颈动脉影像学检查。（证据级别：C；推荐强度：III） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
不建议NCS患者术前行颈动脉影像学检查。（证据级别：C；推荐强度：III）

Preoperative carotid artery imaging is not recommended routinely in patients undergoing non-cardiac surgery(NCS).(Evidence: Level C，Recommendation: Class III)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2221 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2221.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with renal disease requiring peri-operative contrast-enhanced radiography, balanced hydration with i.v. isotonic fluids, the use of a minimal volume of contrast media, and the use of low-osmolar or iso-osmolar contrast media should be considered.(Evidence: Level B，Recommendation: Class IIa) [laiyuan] => 对合并肾脏疾病且围手术期需要行造影剂增强影像学检查的患者，应使用等张液进行容量管理以维持体液平衡，尽量使用低渗或等渗造影剂并减少造影剂用量。（证据级别：B；推荐强度：IIa） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
对合并肾脏疾病且围手术期需要行造影剂增强影像学检查的患者，应使用等张液进行容量管理以维持体液平衡，尽量使用低渗或等渗造影剂并减少造影剂用量。（证据级别：B；推荐强度：IIa）

In patients with renal disease requiring peri-operative contrast-enhanced radiography, balanced hydration with i.v. isotonic fluids, the use of a minimal volume of contrast media, and the use of low-osmolar or iso-osmolar contrast media should be considered.(Evidence: Level B，Recommendation: Class IIa)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2222 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2222.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with known risk factors (age .65 years, BMI .30 kg/m2, diabetes, hypertension, hyperlipidaemia, CV disease, or smoking) undergoing intermediate- or high-risk NCS, it is recommended to screen for pre-operative renal disease by measuring serum creatinine and GFR.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 对存在危险因素（年龄＞65 岁、BMI＞30 kg/m2、糖尿病、高血压、高脂血症、心血管疾病或吸烟）且拟行中-高风险非心脏手术的患者，建议术前检查血清肌酐和肾小球滤过率（GFR）以排除肾脏疾病。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
对存在危险因素（年龄＞65 岁、BMI＞30 kg/m2、糖尿病、高血压、高脂血症、心血管疾病或吸烟）且拟行中-高风险非心脏手术的患者，建议术前检查血清肌酐和肾小球滤过率（GFR）以排除肾脏疾病。（证据级别：C；推荐强度：I）

In patients with known risk factors (age .65 years, BMI .30 kg/m2, diabetes, hypertension, hyperlipidaemia, CV disease, or smoking) undergoing intermediate- or high-risk NCS, it is recommended to screen for pre-operative renal disease by measuring serum creatinine and GFR.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2223 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2223.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => If a cystatin C measurement assay is available, cystatin C measurement should be considered in patients with impaired eGFR (,45–59 mL/min/ 1.73 m2) to confirm kidney disease.(Evidence: Level C，Recommendation: Class IIa) [laiyuan] => 对肾小球滤过率估值（eGFR）降低[< 45～ 49 ml /（min·1.73m2）]的患者，有条件时应检查胱抑素C，以明确是否合并肾病。（证据级别：C；推荐强度：IIa） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
对肾小球滤过率估值（eGFR）降低[< 45～ 49 ml /（min·1.73m2）]的患者，有条件时应检查胱抑素C，以明确是否合并肾病。（证据级别：C；推荐强度：IIa）

If a cystatin C measurement assay is available, cystatin C measurement should be considered in patients with impaired eGFR (,45–59 mL/min/ 1.73 m2) to confirm kidney disease.(Evidence: Level C，Recommendation: Class IIa)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2224 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2224.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => It is recommended to assess cardiorespiratory fitness to estimate peri-operative CV risk in obese patients, with particular attention to those undergoing intermediate- and high-risk NCS.(Evidence: Level B，Recommendation: Class I) [laiyuan] => 建议对肥胖患者行术前呼吸循环系统检查以评估围手术期心血管风险，尤其对于拟行中-高风险NCS者。（证据级别：B；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
建议对肥胖患者行术前呼吸循环系统检查以评估围手术期心血管风险，尤其对于拟行中-高风险NCS者。（证据级别：B；推荐强度：I）

It is recommended to assess cardiorespiratory fitness to estimate peri-operative CV risk in obese patients, with particular attention to those undergoing intermediate- and high-risk NCS.(Evidence: Level B，Recommendation: Class I)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2225 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2225.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients at high risk of obesity hypoventilation syndrome, additional specialist investigation before major elective NCS should be considered.(Evidence: Level C，Recommendation: Class IIa) [laiyuan] => 对存在肥胖低通气综合征高风险患者，建议行重大手术前行相关专科检查。（证据级别：C；推荐强度：IIa） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
对存在肥胖低通气综合征高风险患者，建议行重大手术前行相关专科检查。（证据级别：C；推荐强度：IIa）

In patients at high risk of obesity hypoventilation syndrome, additional specialist investigation before major elective NCS should be considered.(Evidence: Level C，Recommendation: Class IIa)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2226 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2226.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with diabetes or disturbed glucose metabolism, a pre-operative HbA1c test is recommended, if this measurement has been not performed in the previous 3 months. In case of HbA1c ≥8.5% (≥69 mmol/mol), elective NCS should be postponed, if safe and practical.(Evidence: Level B，Recommendation: Class I) [laiyuan] => 建议术前3个月未行糖化血红蛋 白（HbA1c）检查的 DM 或糖代谢紊乱患者，术前行HbA1c检查。如果术前 HbA1c ≥8.5%（≥ 69 mmol/mol），建议综合评估患者安全及可行性后暂缓择期 NCS。（证据级别：B；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
建议术前3个月未行糖化血红蛋 白（HbA1c）检查的 DM 或糖代谢紊乱患者，术前行HbA1c检查。如果术前 HbA1c ≥8.5%（≥ 69 mmol/mol），建议综合评估患者安全及可行性后暂缓择期 NCS。（证据级别：B；推荐强度：I）

In patients with diabetes or disturbed glucose metabolism, a pre-operative HbA1c test is recommended, if this measurement has been not performed in the previous 3 months. In case of HbA1c ≥8.5% (≥69 mmol/mol), elective NCS should be postponed, if safe and practical.(Evidence: Level B，Recommendation: Class I)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2227 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2227.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => A pre-operative assessment for concomitant cardiac conditions is recommended in patients with diabetes with suspected or known CAD, and those with autonomic neuropathy, retinopathy, or renal disease and scheduled to undergo intermediateor high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 对于患有DM+疑似/确诊CAD或自主神经病变、视网膜病变或肾脏疾病且拟行中-高风险NCS的患者，术前应同时行心血管评估.（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
对于患有DM+疑似/确诊CAD或自主神经病变、视网膜病变或肾脏疾病且拟行中-高风险NCS的患者，术前应同时行心血管评估.（证据级别：C；推荐强度：I）

A pre-operative assessment for concomitant cardiac conditions is recommended in patients with diabetes with suspected or known CAD, and those with autonomic neuropathy, retinopathy, or renal disease and scheduled to undergo intermediateor high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2228 [catid] => 197 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2228.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In order to preserve optimal CV stability, it is recommended to apply goal-directed haemodynamic therapy in patients undergoing high-risk NCS.(Evidence: Level A ，Recommendation: Class I) [laiyuan] => 为维持高风险患者心血管系统的稳定，建议实施目标导向的血流动力学管理。（证据级别：A；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
为维持高风险患者心血管系统的稳定，建议实施目标导向的血流动力学管理。（证据级别：A；推荐强度：I）

In order to preserve optimal CV stability, it is recommended to apply goal-directed haemodynamic therapy in patients undergoing high-risk NCS.(Evidence: Level A ，Recommendation: Class I)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读

地址：甘肃省兰州市七里河区瓜州路418号

邮编：730050

电话：0931-2687109

商务合作热线：0931-2687106

备案号：陇ICP备17005383号-1 联网备案号：62010302000288

技术支持：瑞秀科技